rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

William P. Donnelly

Director

Company insider

Files Form 4 as: Executive Chair, Quanterix; Director, T. Rowe Price Group; Director, Ingersoll Rand; Executive Vice President, Mettler-Toledo International.

In numbers

Trades disclosed
668
Buys
5
Sells
96
Bought
$2.6M
Sold
$147.5M
Companies
4
Companies where not an officer
2
First trade
19 Apr 2006
Last trade
1 Oct 2026
Last filed
2 Oct 2026

Companies traded

Where they are an officer
QTRX QuanterixDirector, Officer · Life-science tools · last 1 Oct 20264 buys · 0 sells
MTD Mettler-Toledo InternationalOfficer · Life-science tools · last 24 Dec 20180 buys · 96 sells
Everywhere else they filed: board seats, 10% stakes, other companies
TROW T. Rowe Price GroupDirector · Capital Markets & Asset Management · last 29 Sep 20260 buys · 0 sells
IR Ingersoll RandDirector · Machinery · last 26 Feb 20261 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
02Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
1 Oct 2026filed 2 Oct 2026QTRX QuanterixLife-science toolsSEC FORM 4 Code A$24K6,964 at $3.41filing
29 Sep 2026filed 30 Sep 2026TROW T. Rowe Price GroupCapital Markets & Asset ManagementSEC FORM 4 Code A$17K163.993 at $104.51filing
29 Sep 2026filed 30 Sep 2026TROW T. Rowe Price GroupCapital Markets & Asset ManagementSEC FORM 4 Code A$17K163.99 at $104.51filing
17 Aug 2026filed 19 Aug 2026QTRX QuanterixLife-science toolsSEC FORM 4 Code M—2,802filing
17 Aug 2026filed 19 Aug 2026QTRX Quanterixoption or derivative · Life-science toolsSEC FORM 4 Code M—2,802 at $0.00filing
17 Aug 2026filed 19 Aug 2026QTRX Quanterixoption or derivative · Life-science toolsSEC FORM 4 Code M—2,802 at $0.00filing
17 Aug 2026filed 19 Aug 2026QTRX QuanterixLife-science toolsSEC FORM 4 Code M—2,802filing
13 Aug 2026filed 14 Aug 2026QTRX QuanterixLife-science toolsSEC FORM 4 Bought$212K72,245 at $2.93filing
13 Aug 2026filed 14 Aug 2026QTRX QuanterixLife-science toolsSEC FORM 4 Bought$212K72,245 at $2.93filing
12 Aug 2026filed 14 Aug 2026QTRX QuanterixLife-science toolsSEC FORM 4 Bought$75K27,155 at $2.75filing
12 Aug 2026filed 14 Aug 2026QTRX QuanterixLife-science toolsSEC FORM 4 Bought$75K27,155 at $2.75filing
1 Jul 2026filed 2 Jul 2026QTRX QuanterixLife-science toolsSEC FORM 4 Code A$24K5,472 at $4.34filing
1 Jul 2026filed 2 Jul 2026QTRX QuanterixLife-science toolsSEC FORM 4 Code A$24K5,472 at $4.34filing
30 Jun 2026filed 1 Jul 2026TROW T. Rowe Price GroupCapital Markets & Asset ManagementSEC FORM 4 Code A—576 at $0.00filing
30 Jun 2026filed 1 Jul 2026TROW T. Rowe Price GroupCapital Markets & Asset ManagementSEC FORM 4 Code A—576 at $0.00filing
29 Jun 2026filed 1 Jul 2026TROW T. Rowe Price GroupCapital Markets & Asset ManagementSEC FORM 4 Code A$16K141.685 at $114.38filing
29 Jun 2026filed 1 Jul 2026TROW T. Rowe Price GroupCapital Markets & Asset ManagementSEC FORM 4 Code A$16K141.68 at $114.38filing
8 May 2026filed 11 May 2026TROW T. Rowe Price GroupCapital Markets & Asset ManagementSEC FORM 4 Code A—1,899 at $0.00filing
8 May 2026filed 11 May 2026TROW T. Rowe Price GroupCapital Markets & Asset ManagementSEC FORM 4 Code A—1,899 at $0.00filing
1 Apr 2026filed 7 Apr 2026QTRX QuanterixLife-science toolsSEC FORM 4 Code A—6,178 at $0.00filing

The newest 500 lines are listed; the numbers count every line.

News

Twist Bioscience (NASDAQ:TWST) versus Quanterix (NASDAQ:QTRX) Financial AnalysisQTRX · tickerreport.com · 15 Oct 2026

0 headlines in the last 90 days name William P. Donnelly; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care100
Industrials1

Buys in green, sells in red, by the company’s sector.

Related people

Michael Francis MillerChief Technology Officer · Chief Technology Officer at Quanterix, filing Form 4 there in the last year
Ivana Magovcevic-LiebischDirector · Director at Quanterix, filing Form 4 there in the last year
Scott MendelDirector · Director at Quanterix, filing Form 4 there in the last year
James Edward Gute Jr.Chief Commercial Officer · Chief Commercial Officer at Quanterix, filing Form 4 there in the last year
Natalia Shuman-FabbriPresident and CEO · Director at Mettler Toledo International Inc/, filing Form 4 there in the last year
Ro KhannaRepresentative, CA-17 · Also traded IR in the last 90 days
Patrick KaltenbachPresident and CEO · Also traded MTD in the last 90 days
Thomas P. SaliceDirector · Also traded MTD in the last 90 days